Ramchand, Sabashini K.
Seeman, Ego
Article History
First Online: 5 September 2018
Compliance with Ethical Standards
:
: Ego Seeman reports research support and lecture fees from Amgen, Allergan, and Eli Lilly, outside the submitted work. Dr. Seeman also has a patent (StrAx1.0) and is the director of the board and shareholder of StraxCorp. Sabashini Ramchand declares no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.